期刊文献+

Anti-hEGFR轻、重链共表达及高表达细胞株快速筛选 被引量:2

Co-expression of anti-hEGFR light and heavy chain and rapid screening of cell lines
下载PDF
导出
摘要 为实现h EGFR全长抗体(anti-h EGFR)轻、重链共表达以及建立快速、高效筛选方法并获得共表达细胞株。采用分子克隆技术获得重链和轻链基因,将之连入peedual真核表达载体;经GS-Neo加压及流式细胞术筛选获得稳定表达细胞株;通过protein A亲和层析技术纯化出目标抗体;应用cck-8法、Annexin V/PI法以及q PCR技术检测anti-h EGFR对A431细胞增殖、凋亡影响。SDS-PAGE分析结果显示,纯化后抗体纯度为95.0%、分子质量约为150 ku。cck-8试验中不同浓度anti-h EGFR对A431细胞增殖均有极显著抑制作用,且与商品化Cetuximab效果相近;anti-h EGFR与Cetuximab均可诱导A431细胞产生凋亡,作用效果相近,均达极显著。全长抗体轻、重链的共表达,省去分别表达的重组过程,保证抗体天然结构;GS-Neo双加压结合流式筛选,实现阳性细胞株快速、高效分离;建立省时、高效抗体共表达平台,为抗体类药物真核构建及筛选提供新思路。 The aim of this study was to co-express h EGFR full length antibody(anti-h EGFR) light and heavy chains, also to establish a rapid screening method and obtain co-expressing cell lines. fulllength heavy chain and light chain were connected to peedual eukaryotic expression vector, which cloned by molecular cloning techniques. stably expressing cell lines were screened by GS-Neo pressure combining flow cytometry; the target antibody was purified by protein A affinity chromatography; To validate the influence for cell proliferation and apoptosis of anti-h EGFR, cck-8 assay,Annexin V/PI method and q PCR were applicated to A431 cell. SDS-PAGE showed that molecular weight of anti-h EGFR was about 150 ku and relative purity was 95.0%. In cck-8 assay, the proliferation of A431 cells were significantly inhibited, and anti-h EGFR had similar effects with Cetuximab. anti-h EGFR had the same effect with Cetuximab in terms of pro-apoptotic of A431 cells. Co-expression could eliminate the refolding process and ensure the activity; The method of GS-Neo pressure combining flow cytometry could achieve a fast and efficient separation of positive cell lines; In this study, the province and efficient co-expression platform was established, which could offer new ideas for the production of antibody drugs.
出处 《东北农业大学学报》 CAS CSCD 北大核心 2015年第10期56-62,共7页 Journal of Northeast Agricultural University
基金 国家自然基金东北农业大学生物学理科基地科研训练及科研能力提高项目(J1210069/J0116) 黑龙江省应用技术研究与开发计划项目(GC13C104)
关键词 anti-hEGFR 共表达载体 GS-Neo筛选 流式细胞术 抗肿瘤 anti-h EGFR co-expression vector GS-Neo screening flow cytometry anti-tumor
  • 相关文献

参考文献16

  • 1Schroeder R L,Stevens C L,Sridhar J,et al.Small molecule tyrosine kinase inhibitors of Erb B2/HER2/Neu in the treatment of aggressive[J].Breast Cancer,2014,19(9):15196-15212.
  • 2Mendelsohn J,Baselga J.Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer[J].Journal of Clinical Oncology,2003,21(14):2787-2799.
  • 3Ravi J,Sneh A,Shilo K,et al.FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway[J].Oncotarget,2014,5(9):2475-2486.
  • 4杜亚利,李琼.表皮生长因子受体拮抗剂在肿瘤靶向治疗中的应用[J].兰州大学学报(医学版),2009,35(3):99-102. 被引量:2
  • 5Pao W,Miller V A,Politi K A,et al.Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated witha second mutation in the EGFR kinase domain[J].Plos Medicine,2005,2(3):225-235.
  • 6陈雪静,常亮,高健.抗肿瘤抗体药物的研究进展[J].中国生物制品学杂志,2015,28(1):84-90. 被引量:12
  • 7刘东海,张更荣,张乐鸣,张顺,董虹.人神经生长因子β亚基cDNA的克隆及在大肠杆菌中的表达[J].中国病理生理杂志,2002,18(5):486-489. 被引量:3
  • 8Gerngross T U.Advances in the production of human therapeutic proteins in yeasts and filamentous fungi[J].Nature Biotechnology,2004,22(11):1409-1414.
  • 9Wurm F M.Production of recombinant protein therapeutics in cultivatedma mamalian cells[J].Nat Biotechnol,2004,22(11):1393-1398.
  • 10Conradt H S,Nitmz M,Dittmar K E,et al.Expression of human interleukin-2 in recombinant baby hamster kidney,Ltk-,andChinese ovary cells.tructure of O-linked carbohydrate chains and their location within the polypeptide[J].J Biol Chem,1989,264(29):17368-17373.

二级参考文献88

  • 1李鹏,邢杰.中性粒细胞的分离与纯化[J].医学理论与实践,2005,18(3):272-275. 被引量:14
  • 2李御宇,黄秉仁,蔡良琬.中国人神经生长因子基因(β-NGF)的扩增、克隆及序列分析[J].中国医学科学院学报,1994,16(5):334-338. 被引量:8
  • 3吴胤瑛,李恩孝.VEGF在恶性肿瘤中的研究进展[J].现代肿瘤医学,2005,13(5). 被引量:56
  • 4Grogan W M, Collins J M. Guide to flow cytrometrymethods[M]. NewYork: Marcel Dekker, 1990: 29-190.
  • 5Lyons P A, Koukoulaki M, Hatton A, et al. Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification[J]. BMC Genomics, 2007(8): 64.
  • 6Lekkerkerker A, Logtenberg T. Phage antibodies against human dendritic cell subpopulations obtained by flow cytometry based selection on freshly isolated cells[J]. J Immunol Methods, 1999, 231(12): 53-63.
  • 7MENDELSOHN J.The epidermal growth factor receptor as a target for cancer therapy[J].Endocr Realt Cancer,2001,8(1):3-9.
  • 8RABEN D,BIANCO C,MILAS L,et al.Targeted therapies and radiation for the treatment of head and neck cancer:are we making progress?[J].Semin in Radiat Oncol,2004,14(2):139-152.
  • 9NORMANNO N,BIANCO C,LUCA A,et al.Targetbased agents against ErbB receptors and their ligands:a novel approach to cancer treatment[J].Endour Realt Cancer,2003,10(1):1-21.
  • 10KIRS M G,NATALE R B,HERBST R S,et al.Efficacy of gefitinib,an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non-small-cell lung cancer:a randomized trial[J].Journal American Medical Association,2003,290(16):2 149-2158.

共引文献55

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部